# Barrett Business Services Inc: financial statements, quarterly

BBSI · Nasdaq · CIK 902791 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbsi.md) · [Financials](/companies/bbsi/financials.md) · [Filings](/companies/bbsi/filings.md) · [Insiders](/companies/bbsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [273](/filings/0000950170-24-122511.md) | [277 d](/filings/0001193125-26-072255.md) | [266](/filings/0000950170-25-066002.md) | [280](/filings/0000950170-25-104269.md) | [294](/filings/0001193125-25-267350.md) | [305 d](/filings/0001193125-26-072255.md) | [293](/filings/0001193125-26-209466.md) | [308](/filings/0001193125-26-335564.md) | [319](/filings/0001193125-25-267350.md) | [321 d](/filings/0001193125-26-072255.md) | [307](/filings/0001193125-26-209466.md) | [319](/filings/0001193125-26-335564.md) |
| Cost of revenue | $m | [205](/filings/0000950170-24-122511.md) | [211 d](/filings/0001193125-26-072255.md) | [226](/filings/0000950170-25-066002.md) | [212](/filings/0000950170-25-104269.md) | [220](/filings/0001193125-25-267350.md) | [233 d](/filings/0001193125-26-072255.md) | [250](/filings/0001193125-26-209466.md) | [234](/filings/0001193125-26-335564.md) | [242](/filings/0001193125-25-267350.md) | [253 d](/filings/0001193125-26-072255.md) | [264](/filings/0001193125-26-209466.md) | [254](/filings/0001193125-26-335564.md) |
| Gross profit | $m | [68.3](/filings/0000950170-24-122511.md) | [65.6 d](/filings/0001193125-26-072255.md) | [39.6](/filings/0000950170-25-066002.md) | [67.9](/filings/0000950170-25-104269.md) | [74.4](/filings/0001193125-25-267350.md) | [71.4 d](/filings/0001193125-26-072255.md) | [42.6](/filings/0001193125-26-209466.md) | [73.3](/filings/0001193125-26-335564.md) | [76.8](/filings/0001193125-25-267350.md) | [68.3 d](/filings/0001193125-26-072255.md) | [43.2](/filings/0001193125-26-209466.md) | [64.9](/filings/0001193125-26-335564.md) |
| Selling, general and administrative | $m | [44.2](/filings/0000950170-24-122511.md) | [45.6 d](/filings/0001193125-26-072255.md) | [42.4](/filings/0000950170-25-066002.md) | [45.6](/filings/0000950170-25-104269.md) | [49.1](/filings/0001193125-25-267350.md) | [48.8 d](/filings/0001193125-26-072255.md) | [44.8](/filings/0001193125-26-209466.md) | [48.2](/filings/0001193125-26-335564.md) | [49.9](/filings/0001193125-25-267350.md) | [47.6 d](/filings/0001193125-26-072255.md) | [47.5](/filings/0001193125-26-209466.md) | [47.2](/filings/0001193125-26-335564.md) |
| Operating income | $m | [22.3](/filings/0000950170-24-122511.md) | [18.2 d](/filings/0001193125-26-072255.md) | [(4.7)](/filings/0000950170-25-066002.md) | [20.4](/filings/0000950170-25-104269.md) | [23.5](/filings/0001193125-25-267350.md) | [20.6 d](/filings/0001193125-26-072255.md) | [(4.2)](/filings/0001193125-26-209466.md) | [23.0](/filings/0001193125-26-335564.md) | [24.8](/filings/0001193125-25-267350.md) | [18.5 d](/filings/0001193125-26-072255.md) | [(6.5)](/filings/0001193125-26-209466.md) | [15.4](/filings/0001193125-26-335564.md) |
| Interest expense | $m | [0.1](/filings/0000950170-23-057611.md) | [0.0 d](/filings/0000950170-24-024024.md) | [0.0](/filings/0000950170-24-051423.md) | [0.0](/filings/0000950170-24-088744.md) | [0.0](/filings/0001193125-25-267350.md) | [0.0 d](/filings/0001193125-26-072255.md) | [0.0](/filings/0001193125-26-209466.md) | [0.0](/filings/0001193125-26-335564.md) | [0.0](/filings/0001193125-25-267350.md) | [0.0 d](/filings/0001193125-26-072255.md) | [0.0](/filings/0001193125-26-209466.md) | [0.0](/filings/0001193125-26-335564.md) |
| Income tax | $m | [6.5](/filings/0000950170-24-122511.md) | [5.1 d](/filings/0001193125-26-072255.md) | [(1.3)](/filings/0000950170-25-066002.md) | [6.8](/filings/0000950170-25-104269.md) | [6.1](/filings/0001193125-25-267350.md) | [6.3 d](/filings/0001193125-26-072255.md) | [(0.5)](/filings/0001193125-26-209466.md) | [6.9](/filings/0001193125-26-335564.md) | [6.1](/filings/0001193125-25-267350.md) | [4.5 d](/filings/0001193125-26-072255.md) | [10.4](/filings/0001193125-26-209466.md) | [4.5](/filings/0001193125-26-335564.md) |
| Net income | $m | [18.2](/filings/0000950170-24-122511.md) | [14.6 d](/filings/0001193125-26-072255.md) | [(0.1)](/filings/0001193125-25-267350.md) | [16.7](/filings/0001193125-25-267350.md) | [19.6](/filings/0001193125-25-267350.md) | [16.8 d](/filings/0001193125-26-072255.md) | [(1.0)](/filings/0001193125-26-335564.md) | [18.5](/filings/0001193125-26-335564.md) | [20.6](/filings/0001193125-25-267350.md) | [16.4 d](/filings/0001193125-26-072255.md) | [(14.8)](/filings/0001193125-26-335564.md) | [12.9](/filings/0001193125-26-335564.md) |
| Diluted EPS | $ per share | [0.67](/filings/0000950170-24-122511.md) | not reported | [(0.01)](/filings/0000950170-25-066002.md) | [0.62](/filings/0000950170-25-104269.md) | [0.74](/filings/0001193125-25-267350.md) | not reported | [(0.04)](/filings/0001193125-26-209466.md) | [0.70](/filings/0001193125-26-335564.md) | [0.79](/filings/0001193125-25-267350.md) | not reported | [(0.59)](/filings/0001193125-26-209466.md) | [0.52](/filings/0001193125-26-335564.md) |
| Basic EPS | $ per share | [0.68](/filings/0000950170-24-122511.md) | not reported | [(0.01)](/filings/0000950170-25-066002.md) | [0.64](/filings/0000950170-25-104269.md) | [0.75](/filings/0001193125-25-267350.md) | not reported | [(0.04)](/filings/0001193125-26-209466.md) | [0.72](/filings/0001193125-26-335564.md) | [0.80](/filings/0001193125-25-267350.md) | not reported | [(0.59)](/filings/0001193125-26-209466.md) | [0.53](/filings/0001193125-26-335564.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [41.6](/filings/0000950170-24-122511.md) | [71.2](/filings/0001193125-26-072255.md) | [51.3](/filings/0000950170-25-066002.md) | [40.3](/filings/0000950170-25-104269.md) | [14.4](/filings/0001193125-25-267350.md) | [55.4](/filings/0001193125-26-335564.md) | [32.0](/filings/0001193125-26-209466.md) | [26.3](/filings/0001193125-26-335564.md) | [47.7](/filings/0001193125-25-267350.md) | [95.0](/filings/0001193125-26-335564.md) | [36.6](/filings/0001193125-26-209466.md) | [27.0](/filings/0001193125-26-335564.md) |
| Current assets | $m | [427](/filings/0000950170-23-057611.md) | [448](/filings/0000950170-25-030223.md) | [475](/filings/0000950170-24-051423.md) | [421](/filings/0000950170-24-088744.md) | [453](/filings/0000950170-24-122511.md) | [475](/filings/0001193125-26-072255.md) | [532](/filings/0000950170-25-066002.md) | [471](/filings/0000950170-25-104269.md) | [517](/filings/0001193125-25-267350.md) | [525](/filings/0001193125-26-335564.md) | [538](/filings/0001193125-26-209466.md) | [466](/filings/0001193125-26-335564.md) |
| Total assets | $m | [690](/filings/0000950170-23-057611.md) | [722](/filings/0000950170-25-030223.md) | [748](/filings/0000950170-24-051423.md) | [689](/filings/0000950170-24-088744.md) | [726](/filings/0000950170-24-122511.md) | [746](/filings/0001193125-26-072255.md) | [779](/filings/0000950170-25-066002.md) | [714](/filings/0000950170-25-104269.md) | [778](/filings/0001193125-25-267350.md) | [779](/filings/0001193125-26-335564.md) | [783](/filings/0001193125-26-209466.md) | [711](/filings/0001193125-26-335564.md) |
| Current liabilities | $m | [341](/filings/0000950170-23-057611.md) | [343](/filings/0000950170-25-030223.md) | [388](/filings/0000950170-24-051423.md) | [333](/filings/0000950170-24-088744.md) | [345](/filings/0000950170-24-122511.md) | [359](/filings/0001193125-26-072255.md) | [438](/filings/0000950170-25-066002.md) | [379](/filings/0000950170-25-104269.md) | [407](/filings/0001193125-25-267350.md) | [406](/filings/0001193125-26-335564.md) | [465](/filings/0001193125-26-209466.md) | [408](/filings/0001193125-26-335564.md) |
| Total liabilities | $m | [510](/filings/0000950170-23-057611.md) | [522](/filings/0000950170-25-030223.md) | [558](/filings/0000950170-24-051423.md) | [490](/filings/0000950170-24-088744.md) | [510](/filings/0000950170-24-122511.md) | [524](/filings/0001193125-26-072255.md) | [565](/filings/0000950170-25-066002.md) | [488](/filings/0000950170-25-104269.md) | [538](/filings/0001193125-25-267350.md) | [538](/filings/0001193125-26-335564.md) | [578](/filings/0001193125-26-209466.md) | [507](/filings/0001193125-26-335564.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [180](/filings/0000950170-24-122511.md) | [199](/filings/0001193125-26-072255.md) | [190](/filings/0001193125-25-267350.md) | [199](/filings/0001193125-25-267350.md) | [215](/filings/0001193125-25-267350.md) | [221](/filings/0001193125-26-335564.md) | [213](/filings/0001193125-26-335564.md) | [226](/filings/0001193125-26-335564.md) | [240](/filings/0001193125-25-267350.md) | [241](/filings/0001193125-26-335564.md) | [206](/filings/0001193125-26-335564.md) | [204](/filings/0001193125-26-335564.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.2 d](/filings/0000950170-24-122511.md) | [57.2 d](/filings/0001193125-26-072255.md) | [9.0](/filings/0000950170-25-066002.md) | [(51.3) d](/filings/0000950170-25-104269.md) | [(0.9) d](/filings/0001193125-25-267350.md) | [53.4 d](/filings/0001193125-26-072255.md) | [5.2](/filings/0001193125-26-209466.md) | [(53.8) d](/filings/0001193125-26-335564.md) | [38.4 d](/filings/0001193125-25-267350.md) | [76.1 d](/filings/0001193125-26-072255.md) | [(22.1)](/filings/0001193125-26-209466.md) | [(55.9) d](/filings/0001193125-26-335564.md) |
| Capital expenditure | $m | [2.3 d](/filings/0000950170-24-122511.md) | [3.7 d](/filings/0001193125-26-072255.md) | [2.8](/filings/0000950170-25-066002.md) | [4.9 d](/filings/0000950170-25-104269.md) | [3.3 d](/filings/0001193125-25-267350.md) | [3.2 d](/filings/0001193125-26-072255.md) | [4.5](/filings/0001193125-26-209466.md) | [4.4 d](/filings/0001193125-26-335564.md) | [4.4 d](/filings/0001193125-25-267350.md) | [5.5 d](/filings/0001193125-26-072255.md) | [5.7](/filings/0001193125-26-209466.md) | [5.5 d](/filings/0001193125-26-335564.md) |
| Dividends paid | $m | [2.0 d](/filings/0000950170-24-122511.md) | [2.0 d](/filings/0001193125-26-072255.md) | [2.0](/filings/0000950170-25-066002.md) | [2.0 d](/filings/0000950170-25-104269.md) | [2.1 d](/filings/0001193125-25-267350.md) | [2.1 d](/filings/0001193125-26-072255.md) | [2.1](/filings/0001193125-26-209466.md) | [2.0 d](/filings/0001193125-26-335564.md) | [2.1 d](/filings/0001193125-25-267350.md) | [2.0 d](/filings/0001193125-26-072255.md) | [2.0](/filings/0001193125-26-209466.md) | [1.9 d](/filings/0001193125-26-335564.md) |
| Share repurchases | $m | [10.9 d](/filings/0000950170-24-122511.md) | [5.1 d](/filings/0001193125-26-072255.md) | [7.1](/filings/0000950170-25-066002.md) | [7.0 d](/filings/0000950170-25-104269.md) | [8.0 d](/filings/0001193125-25-267350.md) | [7.0 d](/filings/0001193125-26-072255.md) | [9.2](/filings/0001193125-26-209466.md) | [8.1 d](/filings/0001193125-26-335564.md) | [7.5 d](/filings/0001193125-25-267350.md) | [17.1 d](/filings/0001193125-26-072255.md) | [20.3](/filings/0001193125-26-209466.md) | [15.2 d](/filings/0001193125-26-335564.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.1](/filings/0000950170-23-057611.md) | [7.0](/filings/0000950170-24-051423.md) | [27.5](/filings/0000950170-24-088744.md) | [27.2](/filings/0000950170-24-122511.md) | [26.3](/filings/0000950170-25-066002.md) | [26.8](/filings/0000950170-25-104269.md) | [26.6](/filings/0001193125-25-267350.md) | [25.8](/filings/0001193125-26-209466.md) | [26.2](/filings/0001193125-26-335564.md) | [26.2](/filings/0001193125-25-267350.md) | [25.0](/filings/0001193125-26-209466.md) | [24.7](/filings/0001193125-26-335564.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,235,180 at 2026-07-22, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-335564.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.